Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges. | Int J Mol Sci | 2022 | 35742921 | PubTator, text mining | PubMed |
| Endothelial Dysfunction in Acute Hepatic Porphyrias. | Diagnostics (Basel) | 2022 | 35741113 | PubTator, text mining | PubMed |
| Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy. | Drug Des Devel Ther | 2022 | 35734365 | PubTator, text mining | PubMed |
| Acute intermittent porphyria: prevalence of pathogenic HMBS variants in China, and epidemiological survey in Hebei Province, China. | Ann Transl Med | 2022 | 35722412 | PubTator, text mining | PubMed |
| Derivative Matrix-Isopotential Synchronous Spectrofluorimetry and Hantzsch Reaction: A Direct Route to Simultaneous Determination of Urinary δ-Aminolevulinic Acid and Porphobilinogen. | Front Chem | 2022 | 35711951 | PubTator, text mining | PubMed |
| The Underlying Molecular Basis and Mechanisms of Venous Thrombosis in Patients with Osteomyelitis: A Data-Driven Analysis. | Genet Res (Camb) | 2022 | 35711689 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension. | Sci Rep | 2022 | 35710932 | PubTator, text mining | PubMed |
| Modulation and proteomic changes on the heme pathway following treatment with 5-aminolevulinic acid. | J Photochem Photobiol B | 2022 | 35671620 | PubTator, text mining | PubMed |
| Systemic Lupus Erythematosus and Hereditary Coproporphyria: Two Different Entities Diagnosed by WES in the Same Patient. | Biomed Res Int | 2022 | 35669728 | PubTator, text mining | PubMed |
| Delirium with delayed diagnosis of hereditary coproporphyria. | Clin Case Rep | 2022 | 35662770 | PubTator, text mining | PubMed |
| Stress routes clients to the proteasome via a BAG2 ubiquitin-independent degradation condensate. | Nat Commun | 2022 | 35654899 | PubTator, text mining | PubMed |
| Raw diffraction data are our ground truth from which all subsequent workflows develop. | Acta Crystallogr D Struct Biol | 2022 | 35647915 | PubTator, text mining | PubMed |
| Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma. | J Hepatol | 2022 | 35636578 | PubTator, text mining | PubMed |
| Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma. | Cancer Sci | 2022 | 35633182 | PubTator, text mining | PubMed |
| Nrf2 Activation With CDDO-Methyl Promotes Beneficial and Deleterious Clinical Effects in Transgenic Mice With Sickle Cell Anemia. | Front Pharmacol | 2022 | 35620281 | PubTator, text mining | PubMed |
| Profiling the quantitative occupancy of myriad transcription factors across conditions by modeling chromatin accessibility data. | Genome Res | 2022 | 35609992 | PubTator, text mining | PubMed |
| Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging. | Nat Neurosci | 2022 | 35606419 | PubTator, text mining | PubMed |
| mRNA-based therapeutics: powerful and versatile tools to combat diseases. | Signal Transduct Target Ther | 2022 | 35597779 | PubTator, text mining | PubMed |
| Altered Mitochondrial Protein Homeostasis and Proteinopathies. | Front Mol Neurosci | 2022 | 35571369 | PubTator, text mining | PubMed |
| Novel insight into the role of clusterin on intraocular pressure regulation by modifying actin polymerization and extracellular matrix remodeling in the trabecular meshwork. | J Cell Physiol | 2022 | 35567755 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=26